“Curcumin for monoclonal gammopathies. What can we hope for, what should we fear.” My comments on the Vermorken study, 2012. Part III.

Work always seems to get in the way of posting anything serious, including this final rant, uhm…I mean, final part of my three-part series on the 2012 Vermorken et al study. But I finally got to it, even though I really should be working, y’know…Cat food is expensive! Here goes!  CHAPTER FIVE. The part that […]